Sleep therapy may tame blood sugar and metabolic risks
NCT ID NCT07333586
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a type of talk therapy for insomnia (CBT-I) can also improve markers of metabolic syndrome, like blood sugar and insulin resistance. Twenty adults with insomnia and higher body weight will be randomly assigned to CBT-I or basic sleep tips for 5 weeks. Researchers will measure sleep, activity, and blood work before and after the treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- A smartphone intervention aims to improve teen sleep and mental health
- Digital sleep and mood programs put to the test for breast cancer survivors
- Online sleep therapy may ease migraines in teens
- A Two-Question survey could help doctors catch sleep disorders earlier
- New sleep drug aims to help Parkinson's patients get a good Night's rest